MBX Biosciences, Inc. Common Stock(MBX:US)
Market Cap$2.36B
Key Metrics
Price$49.61
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$86.61M
EBITDA (TTM)-$98.56M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$45.21M
Total Assets$452.7M
Net Assets$437.76M
Total Debt$555K
Key Metrics
Price$49.61
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$86.61M
EBITDA (TTM)-$98.56M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$45.21M
Total Assets$452.7M
Net Assets$437.76M
Total Debt$555K
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - |
| $27.27M | $25.8M | $23.93M | $21.81M | $26.53M | $18.61M | $19.61M | $16.66M | $9.99M | $10.95M | |
| Research and Development | $18.47M | $19.76M | $19.27M | $17.72M | $22.41M | $15.22M | $16.75M | $14.4M | $7.73M | $9.07M |
| Selling, General, and Administrative | $8.79M | $6.04M | $4.66M | $4.08M | $4.12M | $3.39M | $2.87M | $2.26M | $2.26M | $1.87M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$27.27M | -$25.8M | -$23.93M | -$21.81M | -$26.53M | -$18.61M | -$19.61M | -$16.66M | -$9.99M | -$10.95M |
| $3.75M | $3.73M | $2.31M | $2.39M | $2.65M | $3.02M | $1.47M | $801K | $1.15M | $783K | |
| Non-Operating Interest Income | $3.75M | $3.73M | $2.31M | $2.39M | $2.65M | $3.02M | $1.47M | $801K | $1.15M | $783K |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | - | - | - | - | - | - | - | - | - | - |
Income Before Tax | -$23.52M | -$22.06M | -$21.62M | -$19.41M | -$23.88M | -$15.59M | -$18.14M | -$15.86M | -$8.84M | -$10.16M |
Income Tax | - | - | - | - | - | - | - | - | - | - |
Net Income | -$23.52M | -$22.06M | -$21.62M | -$19.41M | -$23.88M | -$15.59M | -$18.14M | -$15.86M | -$8.84M | -$10.16M |
Minority Interests | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$23.52M | -$22.06M | -$21.62M | -$19.41M | -$23.88M | -$15.59M | -$18.14M | -$15.86M | -$8.84M | -$10.16M |
Shares Outstanding (Basic) | 46.58M | 44.87M | 34.2M | 33.45M | 33.41M | 33.39M | 6.52M | - | - | 31.85M |
Shares Outstanding (Diluted) | 46.58M | 44.87M | 34.2M | 33.45M | 33.41M | 33.39M | 6.52M | - | - | 31.85M |
EPS (Basic) | -$0.50 | -$0.49 | -$0.63 | -$0.58 | -$0.71 | -$0.47 | -$2.78 | - | - | -$0.32 |
EPS (Diluted) | -$0.50 | -$0.49 | -$0.63 | -$0.58 | -$0.71 | -$0.47 | -$2.78 | - | - | -$0.32 |
EBIT | -$27.27M | -$25.8M | -$23.93M | -$21.81M | -$26.53M | -$18.61M | -$19.61M | -$16.66M | -$7.24M | -$10.95M |
EBITDA | -$27.2M | -$25.74M | -$23.88M | -$21.74M | -$26.45M | -$18.55M | -$19.54M | -$16.6M | -$7.2M | -$10.91M |